Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up.

Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up.
复制标题

DOI:
10.3390/ijerph17228608
复制
发表时间:
2020-11-19
影响因子:
--
通讯作者:
Hayes SC
Hayes SC
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Gordon LG;Eakin EG;Spence RR;Pyke C;Bashford J;Saunders C;Hayes SC

文献摘要

参考文献

被引文献

相似文献

研究表明,对于改善乳腺癌女性预后的运动干预是否具有成本效益,结果存在矛盾。我们模拟了运动促进健康干预措施与常规护理的长期成本效益。从社会角度构建了早期乳腺癌女性终生马尔可夫队列模型。数据来自试验、流行病学、生活质量和医疗费用报告。结果是根据 5000 次蒙特卡罗模拟以及单向和概率敏感性分析计算得出的。在队列的剩余寿命中,与常规护理组相比,运动组的增量成本为 7409 美元,获得的质量调整生命年 (QALY) 为 0.35,导致每个 QALY 比率的增量成本为 21,247 澳元(95% 不确定性区间 (UI):主导,31,398 澳元)。运动干预在可接受水平上具有成本效益的可能性为 93.0%。每生命年增加的成本为 AU$8894(95% UI 主导,AU$11,769),具有成本效益的概率为 99.4%。研究结果对运动组和常规护理组的复发概率最为敏感,其次是自付费用和模型起始年龄。这种针对早期乳腺癌后女性的运动干预具有成本效益,并且将是医疗保健资源的合理投资。
Studies show conflicting results on whether exercise interventions to improve outcomes for women with breast cancer are cost-effective. We modelled the long-term cost-effectiveness of the Exercise for Health intervention compared with usual care. A lifetime Markov cohort model for women with early breast cancer was constructed taking a societal perspective. Data were obtained from trial, epidemiological, quality of life, and healthcare cost reports. Outcomes were calculated from 5000 Monte Carlo simulations, and one-way and probabilistic sensitivity analyses. Over the cohort’s remaining life, the incremental cost for the exercise versus usual care groups were $7409 and quality-adjusted life years (QALYs) gained were 0.35 resulting in an incremental cost per QALY ratio of AU$21,247 (95% Uncertainty Interval (UI): Dominant, AU$31,398). The likelihood that the exercise intervention was cost-effective at acceptable levels was 93.0%. The incremental cost per life year gained was AU$8894 (95% UI Dominant, AU$11,769) with a 99.4% probability of being cost effective. Findings were most sensitive to the probability of recurrence in the exercise and usual care groups, followed by the costs of out-of-pocket expenses and the model starting age. This exercise intervention for women after early-stage breast cancer is cost-effective and would be a sound investment of healthcare resources.
DOI: 10.1371/journal.pone.0167521
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者:
Carter HE;Schofield DJ;Shrestha R
通讯作者: Shrestha R
DOI: 10.2165/00019053-200725010-00002
发表时间: 2007-01-01
期刊: PHARMACOECONOMICS
影响因子: 4.4
作者:
Fleurence, Rachael L.;Hollenbeak, Christopher S.
通讯作者: Hollenbeak, Christopher S.
DOI: 10.5694/mja18.00199
发表时间: 2018-08-20
影响因子: 11.4
作者:
Cormie, Prue;Atkinson, Morgan;Adams, Diana
通讯作者: Adams, Diana
DOI: 10.1016/s2214-109x(20)30215-1
发表时间: 2020-08-01
影响因子: 34.3
作者:
Heer, Emily;Harper, Andrew;Fidler-Benaoudia, Miranda M.
通讯作者: Fidler-Benaoudia, Miranda M.
DOI: 10.1007/s10549-010-1126-2
发表时间: 2010-11-01
影响因子: 3.8
作者:
Haines, Terry P.;Sinnamon, Patricia;Smith, Amanda
通讯作者: Smith, Amanda